Azenta Inc (AZTA)
50.47
-0.48
(-0.94%)
USD |
NASDAQ |
May 31, 16:00
50.46
-0.01
(-0.02%)
After-Hours: 20:00
Azenta Cash from Financing (Quarterly): -74.07M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -74.07M |
December 31, 2023 | -113.15M |
September 30, 2023 | -166.86M |
June 30, 2023 | -172.08M |
March 31, 2023 | -0.416M |
December 31, 2022 | -504.72M |
September 30, 2022 | 1.751M |
June 30, 2022 | -1.043M |
March 31, 2022 | -55.79M |
December 31, 2021 | -7.68M |
September 30, 2021 | -4.458M |
June 30, 2021 | -8.123M |
March 31, 2021 | -5.168M |
December 31, 2020 | -8.157M |
September 30, 2020 | -5.443M |
June 30, 2020 | -8.11M |
March 31, 2020 | -5.368M |
December 31, 2019 | -8.102M |
September 30, 2019 | -500.96M |
June 30, 2019 | -10.24M |
March 31, 2019 | -11.38M |
December 31, 2018 | 331.42M |
September 30, 2018 | -6.152M |
June 30, 2018 | -7.577M |
March 31, 2018 | -6.173M |
Date | Value |
---|---|
December 31, 2017 | 190.18M |
September 30, 2017 | -5.921M |
June 30, 2017 | -6.987M |
March 31, 2017 | -6.019M |
December 31, 2016 | -6.993M |
September 30, 2016 | -5.784M |
June 30, 2016 | -7.383M |
March 31, 2016 | -5.946M |
December 31, 2015 | -6.844M |
September 30, 2015 | -14.28M |
June 30, 2015 | -6.873M |
March 31, 2015 | -6.005M |
December 31, 2014 | -6.852M |
September 30, 2014 | -9.288M |
June 30, 2014 | -5.344M |
March 31, 2014 | -4.442M |
December 31, 2013 | -5.391M |
September 30, 2013 | -4.459M |
June 30, 2013 | -5.315M |
March 31, 2013 | -4.392M |
December 31, 2012 | -5.311M |
September 30, 2012 | -4.37M |
June 30, 2012 | -5.278M |
March 31, 2012 | -4.415M |
December 31, 2011 | -5.185M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-504.72M
Minimum
Dec 2022
1.751M
Maximum
Sep 2022
-82.91M
Average
-8.116M
Median
Cash from Financing (Quarterly) Benchmarks
Bruker Corp | 151.70M |
Harvard Bioscience Inc | -1.055M |
Bionano Genomics Inc | -21.62M |
Akoya Biosciences Inc | -0.444M |
Singular Genomics Systems Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 8.356M |
Cash from Investing (Quarterly) | -270.61M |
Free Cash Flow | 54.97M |
Free Cash Flow Per Share (Quarterly) | 0.0276 |
Free Cash Flow to Equity (Quarterly) | 1.529M |
Free Cash Flow to Firm (Quarterly) | 1.529M |
Free Cash Flow Yield | 1.85% |